{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:44:04Z","timestamp":1792439044565,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ihj.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T15:45:34Z","timestamp":1762011934000},"page":"471-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Beta-blocker chronicle: From past principles to present practice \u2013 Implications for the Indian subcontinent"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-0199","authenticated-orcid":false,"given":"Saumitra","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debabrata","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhurjati","family":"Prasad Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiman","family":"Kahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal","family":"Kanti Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyendra","family":"Tewari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hriday","family":"Kumar Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmoy","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ihj.2025.10.006_bib1","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1080\/03007995.2023.2256218","article-title":"Role of \u03b2-blockers in the cardiovascular disease continuum: a collaborative Delphi survey-based consensus from Asia-Pacific","volume":"39","author":"Ray","year":"2023","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.ihj.2025.10.006_bib2","first-page":"e16","article-title":"National consensus statement on role of bisoprolol across cardiovascular continuum: special focus on women","volume":"73","author":"Chopra","year":"2025","journal-title":"J Assoc Phys India"},{"issue":"10","key":"10.1016\/j.ihj.2025.10.006_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.rec.2019.04.006","article-title":"Beta-blockers: historical perspective and mechanisms of action","volume":"72","author":"Oliver","year":"2019","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"key":"10.1016\/j.ihj.2025.10.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lansea.2023.100156","article-title":"The burgeoning cardiovascular disease epidemic in Indians - perspectives on contextual factors and potential solutions","volume":"12","author":"Kalra","year":"2023","journal-title":"The Lancet regional health Southeast Asia"},{"issue":"4","key":"10.1016\/j.ihj.2025.10.006_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/ijerph22040539","article-title":"Prevalence of CVD among Indian adult population: systematic review and meta-analysis","volume":"22","author":"Shannawaz","year":"2025","journal-title":"Int J Environ Res Publ Health"},{"issue":"1","key":"10.1016\/j.ihj.2025.10.006_bib6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5334\/gh.999","article-title":"Research letter: antihypertensive drugs market in India: an insight on size, trends, and prescribing preferences in the private health sector, 2016-2018","volume":"16","author":"Sahoo","year":"2021","journal-title":"Glob Heart"},{"issue":"sup1","key":"10.1016\/j.ihj.2025.10.006_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/03007995.2024.2318058","article-title":"\u03b2-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications","volume":"40","author":"Taddei","year":"2024","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"10.1016\/j.ihj.2025.10.006_bib8","first-page":"S9","article-title":"Contemporary use of \u03b2-Blockers: clinical relevance of subclassification","volume":"30","author":"Poirier","year":"2014","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.ihj.2025.10.006_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/HYPERTENSIONAHA.124.22821","article-title":"Rationale for the inclusion of \u03b2-Blockers among major antihypertensive drugs in the 2023 european society of hypertension guidelines","volume":"81","author":"Mancia","year":"2024","journal-title":"Hypertension"},{"issue":"10153","key":"10.1016\/j.ihj.2025.10.006_bib10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0140-6736(18)31776-8","article-title":"Long-term mortality after blood pressure-lowering and lipid-lowering treatment in patients with hypertension in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) legacy study: 16-year follow-up results of a randomised factorial trial","volume":"392","author":"Gupta","year":"2018","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ihj.2025.10.006_bib11","first-page":"95","article-title":"\u03b2-blockers as the first line of treatment for hypertension management","volume":"79","author":"Ray","year":"2023","journal-title":"J Assoc Phys India"},{"issue":"9395","key":"10.1016\/j.ihj.2025.10.006_bib12","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(03)14739-3","article-title":"Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials","volume":"362","author":"Turnbull","year":"2003","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ihj.2025.10.006_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1503\/cmaj.060110","article-title":"Re-examining the efficacy of \u03b2-blockers for the treatment of hypertension: a meta-analysis","volume":"174","author":"Khan","year":"2006","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"7","key":"10.1016\/j.ihj.2025.10.006_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/HJH.0000000000000614","article-title":"Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs-overview andmeta-analyses","volume":"33","author":"Thomopoulosa","year":"2015","journal-title":"J Hypertens"},{"issue":"10","key":"10.1016\/j.ihj.2025.10.006_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006290","article-title":"Real role of \u03b2-blockers in regression of left ventricular mass in hypertension patients","volume":"96","author":"Xing","year":"2017","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.ihj.2025.10.006_bib16","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/HJH.0000000000002523","article-title":"Beta-blockers in hypertension: overview and meta-analysis of randomized outcome trials","volume":"38","author":"Thomopoulos","year":"2020","journal-title":"J Hypertens"},{"issue":"3","key":"10.1016\/j.ihj.2025.10.006_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/jpcs.jpcs_66_23","article-title":"Understanding the position of beta-blockers in the management of hypertension among patients with different clinical comorbidities: an expert opinion of cardiologists from India","volume":"9","author":"Kumar","year":"2023","journal-title":"J Practice Cardiovasc Sci"},{"issue":"10","key":"10.1016\/j.ihj.2025.10.006_bib18","first-page":"83","article-title":"Position of beta-blockers in the treatment of hypertension today: an Indian consensus","volume":"72","author":"Mohan","year":"2024","journal-title":"J Assoc Phys India"},{"issue":"sup1","key":"10.1016\/j.ihj.2025.10.006_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/03007995.2024.2318002","article-title":"Heart failure management with \u03b2-blockers: can we do better?","volume":"40","author":"de Oliveira","year":"2024","journal-title":"Curr Med Res Opin"},{"issue":"9146","key":"10.1016\/j.ihj.2025.10.006_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"Dargie","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ihj.2025.10.006_bib21","first-page":"20","article-title":"The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial","volume":"2","author":"Eichhorn","year":"2001","journal-title":"Curr Contr Trials Cardiovasc Med"},{"issue":"9169","key":"10.1016\/j.ihj.2025.10.006_bib22","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","author":"Hjalmarson","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ihj.2025.10.006_bib23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","article-title":"A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS investigators and committees","volume":"90","author":"Lechat","year":"1994","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ihj.2025.10.006_bib24","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.105.582320","article-title":"Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III","volume":"112","author":"Willenheimer","year":"2005","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ihj.2025.10.006_bib25","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ihj.2025.10.006_bib26","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ihj.2025.10.006_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/eurheartj\/ehi115","article-title":"Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)","volume":"26","author":"Flather","year":"2005","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ihj.2025.10.006_bib28","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/clc.24058","article-title":"Association between the beta-blockers, calcium channel blockers, all-cause mortality and length of hospitalization in patients with heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials","volume":"46","author":"Wu","year":"2023","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2025.10.006_bib29","doi-asserted-by":"crossref","DOI":"10.2174\/1573403X19666230111143901","article-title":"Smritigandha. Role of \u03b2-blockers in preventing heart failure and major adverse cardiac events post myocardial infarction","volume":"19","author":"Johri","year":"2023","journal-title":"Curr Cardiol Rev"},{"issue":"11","key":"10.1016\/j.ihj.2025.10.006_bib30","first-page":"e32","article-title":"Sympathetic overdrive and role of beta-blockers in various forms of heart failure: a consensus statement from India","volume":"72","author":"Chopra","year":"2024","journal-title":"J Assoc Phys India"},{"issue":"12","key":"10.1016\/j.ihj.2025.10.006_bib31","first-page":"77","article-title":"Role of bisoprolol in heart failure management: a consensus statement from India","volume":"71","author":"Chopra","year":"2023","journal-title":"J Assoc Phys India"},{"issue":"1","key":"10.1016\/j.ihj.2025.10.006_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/heartviews.heartviews_75_22","article-title":"Beta-blockers in the prevention and treatment of ischemic heart disease","volume":"24","author":"Khan","year":"2023","journal-title":"Heart Views"},{"issue":"12","key":"10.1016\/j.ihj.2025.10.006_bib33","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction","volume":"247","year":"1982","journal-title":"JAMA"},{"issue":"9497","key":"10.1016\/j.ihj.2025.10.006_bib34","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ihj.2025.10.006_bib35","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.113.003653","volume":"128","author":"Ibanez","year":"2013","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.ihj.2025.10.006_bib36","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.jacc.2016.03.522","article-title":"Early intravenous beta-blockers in patients with ST-Segment elevation myocardial infarction before primary percutaneous coronary intervention","volume":"67","author":"Roolvink","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ihj.2025.10.006_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcin.2015.10.035","article-title":"Randomized control of sympathetic drive with continuous intravenous esmolol in patients with acute ST-Segment elevation myocardial infarction: the BEtA-Blocker therapy in acute myocardial infarction (BEAT-AMI) trial","volume":"9","author":"Er","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"8","key":"10.1016\/j.ihj.2025.10.006_bib38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjmed.2007.04.016","article-title":"Impact of acute beta-blocker therapy for patients with Non-ST-Segment elevation myocardial infarction","volume":"120","author":"Miller","year":"2007","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ihj.2025.10.006_bib39","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ahj.2006.08.024","article-title":"Patterns of use and potential impact of early \u03b2-blocker therapy in non\u2013ST-elevation myocardial infarction with and without heart failure: the global registry of acute coronary events","volume":"152","author":"Emery","year":"2006","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ihj.2025.10.006_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10557-018-6818-6","article-title":"The use of oral beta-blockers and clinical outcomes in patients with Non-ST-Segment elevation acute coronary syndromes: a long-term Follow-Up study","volume":"32","author":"Nicolau","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.ihj.2025.10.006_bib41","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1016\/0002-9149(87)90494-2","article-title":"Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine\/metoprolol trial (HINT)","volume":"60","author":"Lubsen","year":"1987","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.ihj.2025.10.006_bib42","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0002-9149(88)90543-7","article-title":"Safety and efficacy of esmolol for unstable angina pectoris","volume":"62","author":"Wallis","year":"1988","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ihj.2025.10.006_bib43","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9149(00)00723-2","article-title":"Usefulness of carvedilol in unstable angina pectoris","volume":"85","author":"Brunner","year":"2000","journal-title":"Am J Cardiol"},{"issue":"15","key":"10.1016\/j.ihj.2025.10.006_bib44","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMoa2401479","article-title":"Beta-blockers after myocardial infarction and preserved ejection fraction","volume":"390","author":"Yndigegn","year":"2024","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ihj.2025.10.006_bib45","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2404204","article-title":"ABYSS investigators of the ACTION study group. beta-blocker interruption or continuation after myocardial infarction","volume":"391","author":"Silvain","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2025.10.006_bib46","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2504735","article-title":"Beta-blockers after myocardial infarction without reduced ejection fraction","author":"Ibanez","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ihj.2025.10.006_bib47","article-title":"BETAMI\u2013DANBLOCK investigators. beta-blockers after myocardial infarction in patients without heart failure","volume":"30","author":"Munkhaugen","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ihj.2025.10.006_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ehjcvp\/pvad093","article-title":"The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: design, rationale, and baseline characteristics","volume":"10","author":"Kristensen","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"13","key":"10.1016\/j.ihj.2025.10.006_bib50","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ihj.2025.10.006_bib51","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/heartjnl-2014-305719","article-title":"Prognostic impact of \u00df-blocker use in patients with stable coronary artery disease","volume":"100","author":"Bauters","year":"2014","journal-title":"Heart"},{"issue":"16","key":"10.1016\/j.ihj.2025.10.006_bib52","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jcin.2016.05.048","article-title":"Predictors, trends, and outcomes (Among older patients \u226565 years of age) associated with beta-blocker use in patients with stable angina undergoing elective percutaneous coronary intervention: insights from the NCDR registry","volume":"9","author":"Motivala","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.ihj.2025.10.006_bib53","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","article-title":"Beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease","volume":"64","author":"Andersson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2025.10.006_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1043714","article-title":"Beta-blockers in cardiac arrhythmias\u2013Clinical pharmacologist's point of view","volume":"13","author":"Wo\u0142owiec","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.ihj.2025.10.006_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/euhj.1999.1741","article-title":"The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS study)","volume":"21","author":"Kristal-Boneh","year":"2000","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ihj.2025.10.006_bib56","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1046\/j.1532-5415.2003.51410.x","article-title":"Sex differences in the effect of heart rate on mortality in the elderly","volume":"51","author":"Perk","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"10.1016\/j.ihj.2025.10.006_bib57","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","article-title":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation","volume":"43","author":"Olshansky","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.ihj.2025.10.006_bib58","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.amjcard.2008.07.033","volume":"102","author":"Piccini","year":"2008","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.ihj.2025.10.006_bib59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.amjcard.2005.04.046","article-title":"Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II)","volume":"96","author":"Brodine","year":"2005","journal-title":"Am J Cardiol"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483225002044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483225002044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T17:16:30Z","timestamp":1766250990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483225002044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0019483225002044"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2025.10.006","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Beta-blocker chronicle: From past principles to present practice \u2013 Implications for the Indian subcontinent","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}